Turtle Creek Wealth Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Turtle Creek Wealth Advisors's EW Position: Q1 2026 in Review
Turtle Creek Wealth Advisors increased its Edwards Lifesciences (EW) stake by 15% in Q1 2026, buying an estimated $48.6K and bringing the position to 4,448 shares worth $356K. The position accounts for 0.03% of the portfolio, ranked #290.
Turtle Creek Wealth Advisors first reported a position in EW in Q4 2023 and has held it in 5 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Turtle Creek Wealth Advisors held 4,448 shares of Edwards Lifesciences worth $356K as of Q1 2026.
- Turtle Creek Wealth Advisors bought 589 Edwards Lifesciences shares in Q1 2026, an estimated $48.6K.
- Edwards Lifesciences made up 0.03% of Turtle Creek Wealth Advisors's portfolio in Q1 2026, its #290 holding.
- Turtle Creek Wealth Advisors first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 5 quarters since.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.